BioNovoGene Completes $15 Million Round for Metabolomics Services
May 17, 2021 at 05:24 AM EDT
Suzhou BioNovoGene completed a $15 million Series A funding to support its metabolomics services including mass spectrometry test kits. Founded in 2013, the company has established a complete metabolomics testing and analysis platform. Its cloud data analysis system, BioDeep™ has independent intellectual property rights. The company will use the funds to expand its technology platform and develop additional clinical mass spectrometry test kits/products for metabolomics. The round was led by YuanBio Venture Capital. More details.... Share this with colleagues: // //
